NCT05891171: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers |
|
|
| Recruiting | 1 | 81 | US, RoW | AB598, Zimberelimab, AB122, Carboplatin, Pemetrexed, Fluorouracil, Leucovorin, Oxaliplatin | Arcus Biosciences, Inc. | Advanced Cancer, Advanced Malignancies, Bladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer (GEJ), Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Ovarian Cancer, Renal Cell Carcinoma (RCC), Triple Negative Breast Cancer (TNBC) | 08/25 | 08/25 | | |
